Tag Archives: Life Science

Ex Parte Schwartz – A Pyrrhic Reversal of a 101 Rejection

The PTAB decision reversing the Examiner’s s. 101 rejection in Ex Parte Schwartz, Appeal 2017-004975 (August 2, 2018) both demonstrates the need for more Examiner training on the ever-changing definition/identification of an abstract idea, particularly in the context of inventions … Continue reading

Posted in Section 101 | Tagged , , , , , , | Leave a comment

New Webinar Series: Practical IP for Natural Sciences

Please join us in a new webinar series directed to the practical strategies in a new era of patent law to protect IP in chemistry, pharmaceuticals, biotechnology and genetic medicine. The collision of new technologies and patent statutes of a … Continue reading

Posted in Webinar | Tagged , , , , , , | Leave a comment